Table 1.

Characteristics of the Study Population (Mean ± Standard Error of the Mean)

	Study patients	Nonresponding patients
Number of patients	60	30
Age at breast cancer treatment, years	52 ± 1.3	49 ± 2.0
Age at liposuction, years	64 ± 1.3	60 ± 2.1
Onset (time from breast cancer operation to lymphedema start), years	2 ± 0.4	4 ± 1.1
Duration of lymphedema, years	10 ± 1.3	8 ± 1.2
Duration from breast cancer treatment to liposuction, years	12 ± 1.0	12 ± 1.5

There were no significant differences between the characteristics of the study group and the group of nonresponding patients.